BRCA1-mediated ubiquitylation.

Cell Cycle

DNA Damage Response Laboratory, Cancer Research UK, The London Research Institute, South Mimms EN6 3LD UK.

Published: July 2006

The BRCA1 tumour suppressor and its heterodimeric partner BARD1 play crucial roles in coordinating cellular responses to DNA damage. Evidence also implicates these proteins in transcriptional regulation, cell cycle progression and meiotic sex chromosome inactivation, but their mode of action remains elusive. The demonstration that the BRCA1/BARD1 heterodimer constitutes an E3-ubiquitin (Ub) ligase raises the possibility that ubiquitylation of specific targets may allow BRCA1/BARD1 to impact on diverse cellular processes. It is clear that the E3-Ub ligase activity of BRCA1/BARD1 is of critical functional importance as tumour-derived BRCA1 mutations have been identified that eliminate this activity. Recent work and data presented here indicates that BRCA1/BARD1 function is largely conserved in C. elegans. Indeed, studies in C. elegans and human cells have illuminated how the E3-ubiquitin (Ub) ligase activity is regulated in response to DNA damage. However, bone fide targets for BRCA1-dependent ubiquitylation are not known and their identification remains critical to the understanding of the role of BRCA1 in tumorigenesis.

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.5.14.2930DOI Listing

Publication Analysis

Top Keywords

dna damage
8
e3-ubiquitin ligase
8
ligase activity
8
brca1-mediated ubiquitylation
4
ubiquitylation brca1
4
brca1 tumour
4
tumour suppressor
4
suppressor heterodimeric
4
heterodimeric partner
4
partner bard1
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!